Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Baron

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Intensive Care Medicine|March 10, 2010
Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemiaSigismond Lasocki, Gabriel Baron, Fathi Driss, et al.
BMC Medicine|June 5, 2019
Three randomized controlled trials evaluating the impact of "spin" in health news stories reporting studies of pharmacologic treatments on patients'/caregivers' interpretation of treatment benefitIsabelle Boutron, Romana Haneef, Amélie Yavchitz, et al.
Plos One|January 26, 2013
Development and validation of a questionnaire assessing fears and beliefs of patients with knee osteoarthritis: the Knee Osteoarthritis Fears and Beliefs Questionnaire (KOFBeQ)Mathilde Benhamou, Gabriel Baron, Marie Dalichampt, et al.
Plos One|August 9, 2007
Effect of a simple information booklet on pain persistence after an acute episode of low back pain: a non-randomized trial in a primary care settingEmmanuel Coudeyre, Florence Tubach, François Rannou, et al.
International Journal of Cancer|September 21, 2017
Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional studyJean-David Zeitoun, Gabriel Baron, Alexandre Vivot, et al.
Plos One|July 4, 2008
Knee arthroplasty: disabilities in comparison to the general population and to hip arthroplasty using a French national longitudinal surveyAgnes Dechartres, Isabelle Boutron, Remy Nizard, et al.
The Journal of Rheumatology|April 17, 2004
Social and personal consequences of disability in adults with hip and knee arthroplasty. A French national community based surveyIsabelle Boutron, Serge Poiraudeau, Philippe Ravaud, et al.
Clinical Pharmacology and Therapeutics|January 30, 2018
Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable AnalysisJean-David Zeitoun, Joseph S Ross, Ignacio Atal, et al.
BMJ Open|December 24, 2017
Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional studyJean-David Zeitoun, Joseph S Ross, Ignacio Atal, et al.
Thrombosis Research|August 10, 2011
Elevated soluble endothelial cell protein C receptor (sEPCR) levels in women with preeclampsia: a marker of endothelial activation/damage?Béatrice Saposnik, Edith Peynaud-Debayle, Alain Stepanian, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Intensive Care Medicine|March 10, 2010
Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemiaSigismond Lasocki, Gabriel Baron, Fathi Driss, et al.
BMC Medicine|June 5, 2019
Three randomized controlled trials evaluating the impact of "spin" in health news stories reporting studies of pharmacologic treatments on patients'/caregivers' interpretation of treatment benefitIsabelle Boutron, Romana Haneef, Amélie Yavchitz, et al.
Plos One|January 26, 2013
Development and validation of a questionnaire assessing fears and beliefs of patients with knee osteoarthritis: the Knee Osteoarthritis Fears and Beliefs Questionnaire (KOFBeQ)Mathilde Benhamou, Gabriel Baron, Marie Dalichampt, et al.
Plos One|August 9, 2007
Effect of a simple information booklet on pain persistence after an acute episode of low back pain: a non-randomized trial in a primary care settingEmmanuel Coudeyre, Florence Tubach, François Rannou, et al.
International Journal of Cancer|September 21, 2017
Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional studyJean-David Zeitoun, Gabriel Baron, Alexandre Vivot, et al.
Plos One|July 4, 2008
Knee arthroplasty: disabilities in comparison to the general population and to hip arthroplasty using a French national longitudinal surveyAgnes Dechartres, Isabelle Boutron, Remy Nizard, et al.
The Journal of Rheumatology|April 17, 2004
Social and personal consequences of disability in adults with hip and knee arthroplasty. A French national community based surveyIsabelle Boutron, Serge Poiraudeau, Philippe Ravaud, et al.
Clinical Pharmacology and Therapeutics|January 30, 2018
Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable AnalysisJean-David Zeitoun, Joseph S Ross, Ignacio Atal, et al.
BMJ Open|December 24, 2017
Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional studyJean-David Zeitoun, Joseph S Ross, Ignacio Atal, et al.
Thrombosis Research|August 10, 2011
Elevated soluble endothelial cell protein C receptor (sEPCR) levels in women with preeclampsia: a marker of endothelial activation/damage?Béatrice Saposnik, Edith Peynaud-Debayle, Alain Stepanian, et al.
Pageof 11